From: Oxidative stress and DNA damage in patients with migraine
Demographic variables | TAS (mmolTroloxEqv/L) | p value | TOS (mmolTroloxEqv/L) | p value | 8-OHdG (ng/mL) | p value | |||
---|---|---|---|---|---|---|---|---|---|
Migraine | Control (n = 35) | Migraine | Control | Migraine | Control | ||||
Smoking | 1.88 ± 0.45 | 1.82 ± 0.52 | 0.798 | 5.21 ± 3.8 | 4.06 ± 3.4 | 0.091 | 4.12 ± 1.2 | 3.31 ± 1.8 | 0.001* |
Non-smoking | 1.9 ± 0.89 | 1.94 ± 0.7 | 0.892 | 4.86 ± 3.2 | 3.94 ± 3.1 | 0.064 | 3.96 ± 1.08 | 2.98 ± 1.2 | 0.001* |
p value | 0.639 | 0.017 | 0.768 | 0.518 | 0.465 | 0.662 | |||
Female | 1.7 ± 0.38 | 1.88 ± 0.62 | 0.164 | 4.82 ± 3.9 | 3.86 ± 2.9 | 0.065 | 3.92 ± 1.3 | 2.92 ± 1.8 | 0.001* |
Male | 1.9 ± 0.45 | 1.92 ± 0.48 | 0.692 | 4.99 ± 3.4 | 4.01 ± 3.7 | 0.074 | 4.19 ± 1.1 | 3.38 ± 1.4 | 0.001* |
p value | 0.598 | 0.765 | 0.794 | 0.684 | 0.235 | 0.085 | |||
Drugs (+) | 1.93 ± 0.17 | – | 5.48 ± 3.8 | – | 4.16 ± 1.2 | – | |||
Drugs (−) | 1.85 ± 0.14 | – | 4.49 ± 2.8 | – | 3.99 ± 3.2 | – | |||
p value | 0.103 | 0.290 | 0.336 |